Cho 2015.
| Methods | RCT, cross‐over
Method of randomisation: not stated
Blinding of outcome assessors: not stated
Adverse events: not stated
Deaths: not stated
Dropouts: not stated ITT: not stated |
|
| Participants | Country: Korea
20 participants (13 in treatment group, 7 in control group)
Not ambulatory at start of study
Mean age: 55 years in control and treatment group Inclusion criteria: onset period of > 6 months, FAC < 2, independent ambulation before stroke, ability to understand and execute RAGT, no orthopaedic or neurosurgical problems in the lower extremities Exclusion criteria: weight > 120 kg; femoral length < 35 cm or > 47 cm; history of low‐extremity fracture after stroke, instability or subluxation of the hip joint, or pressure ulcers on the hips or lower extremities; any underlying disease preventing execution of RAGT |
|
| Interventions | 2 arms:
|
|
| Outcomes | Outcomes were recorded at baseline and after 4 and 8 weeks:
|
|
| Notes | Higher dose of intervention in experimental group compared to control group; group differences at baseline (modified forward reach) | |
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Unclear risk | Method of randomisation not described. |
| Allocation concealment (selection bias) | High risk | Allocation not described. |
| Blinding of outcome assessment (detection bias) All outcomes | High risk | Not mentioned |
| Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Unclear |